AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

2025 Avoca Industry Survey

The survey is open — participate now!

 

As an industry professional, you are invited to participate in the 2025 Avoca Industry Survey.

Avoca, a WCG company, is dedicated to increasing quality, improving efficiency, and ensuring compliance in the clinical trial execution process. For more than 20 years, Avoca has surveyed the industry to gain an understanding of key trends affecting clinical development.

This year’s survey aims to understand opinions and experiences as it relates to the final ICH E6 (R3) guidance. We encourage you to participate regardless of your current involvement with this guidance – all feedback is appreciated!

The survey will take approximately 10-15 minutes to complete, and responses will be confidential and anonymous.

A report of aggregate findings will be available in June 2025 under Avoca’s Research Reports library and will offer a comprehensive overview of how finalized ICH E6 (R3) guidelines are being received and implemented across the industry.

We greatly value your input, and we welcome you to share this survey with your colleagues. Please click the link below to get started!

Start Survey ››

 

 

RELATED CONTENT:

WCG’s Avoca Quality Consortium (AQC) can support successful implementation of ICH E6 (R3) with resources including side-by-side comparison tools and recent webinars to enable continuous quality compliance.
Learn more ››

This website uses cookies to improve functionality and performance. If you continue browsing the site, you are giving implied consent to the use of cookies on this website. See our Privacy Policy for details.

I Accept